Henry Schein, Inc. HSIC

Full chart Compare
Set alert

Price alert · HSIC

All alert types
82.15 USD -4.48 (-5.17%)

Nov 3, 2026, 3:42 PM EST

81.05 Day range 86.87
64.64 52-week range 90.86
YTD
+8.69%
1 year
+27.08%
Market cap
9.16B
Revenue (ttm)
13.60B
Profit margin
2.96%
EPS (ttm)
3.43
Shares out
111.45M
P/E ratio
23.96
Forward P/E
14.46
YTD return
+8.69%
1-year return
+27.08%
Volume
3.05M
Avg volume
1.17M
Open
82.37
Previous close
86.62
Day's range
81.05 – 86.87
52-week range
64.64 – 90.86
Beta
0.86
Analysts
Buy
Price target
96.87 (+17.9%)
Earnings date
Nov 3, 2026

6M +10.48 (+14.55%)

708090May 21Jun 29Aug 5Sep 10Oct 1582.50

Key statistics

Enterprise value
14.68B
PEG ratio
1.69
Price / sales
0.71
Price / book
3.07
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
6.70%
Free cash flow
446.00M
Total cash
157.00M
Total debt
3.81B
Return on equity
8.85%
Short % of float
9.79%
50-day average
86.53
200-day average
81.06

Financials — quick view

All financials
HSIC Revenue — quarterly 3.46B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
HSIC Net income — quarterly 94.00M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
HSIC EPS — quarterly 0.83
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

HSIC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 3, 2026Sep 27, 20261.36———
Aug 4, 2026Jun 27, 20261.241.27+0.03+2.42%
May 5, 2026Mar 28, 20261.201.32+0.12+10.00%
Feb 24, 2026Dec 27, 20251.301.34+0.04+3.08%
Nov 4, 2025Sep 27, 20251.271.38+0.11+8.66%
Aug 5, 2025Jun 28, 20251.181.10-0.08-6.78%

Upgrades / downgrades

HSIC analyst upgrades and downgrades
DateFirmActionFromTo
Oct 14, 2026Leerink PartnersmainMarket PerformMarket Perform
Aug 19, 2026BTIGmainBuyBuy
Aug 6, 2026BarclaysmainOverweightOverweight
Aug 5, 2026UBSmainNeutralNeutral
Aug 5, 2026CitigroupmainBuyBuy
Aug 5, 2026BTIGreitBuyBuy

About Henry Schein, Inc.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Sector
Healthcare
Industry
Medical Distribution
Country
United States

News

Your note

Sign in to keep a note on HSIC — it syncs with the Stock Master app.

Insider holders

HSIC insider holders
InsiderRelationLatest transactionDateShares held
ALBERTINI ANDREAOfficerStock Award(Grant)Mar 5, 2026122,092
BERGMAN STANLEY MDirectorStock GiftMay 25, 2026643,124
BRESLAWSKI JAMES PPresidentStock Award(Grant)Mar 9, 2025206,542
CONNETT BRADFORD COfficerSaleMar 18, 202562,688
ETTINGER MICHAEL S.Chief Operating OfficerStock GiftMar 16, 2026112,418
LOWERY FREDERICK M.Chief Executive OfficerStock Award(Grant)Mar 5, 202695,156

Institution ownership

HSIC institution ownership
Holder% heldSharesValueReported
Kohlberg Kravis Roberts & Co. L.P.14.04%15,652,0321.36BJun 29, 2026
FMR, LLC6.78%7,553,901654.32MJun 29, 2026
Blackrock Inc.6.30%7,024,663608.48MJun 29, 2026
Artisan Partners Limited Partnership5.80%6,467,467560.21MJun 29, 2026
Vanguard Capital Management LLC5.69%6,346,669549.75MJun 29, 2026
JPMORGAN CHASE & CO3.90%4,342,929376.18MJun 29, 2026

Fund ownership

HSIC fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.77%3,088,611267.54MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.25%2,507,310217.18MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.00%2,231,443193.29MJun 29, 2026
Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF2.00%2,223,555192.60MSep 29, 2026
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund1.94%2,164,774187.51MJul 30, 2026
J.P. Morgan Fleming Mutual Fd. Group, Inc.-JPMorgan Mid Cap Value Fd.1.44%1,606,529139.16MJun 29, 2026